S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
GLP · Global Partners LP
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
$49.55
-0.83
(-1.64%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$49.55
$49.55
$50.78
52-WEEK RANGE
$49.55
$39.58
$54.29
What's happening
- GLP is down 1.64% today, trading at $49.55. — Live quote
- Volume today (1,687) is well below its 3-month average of 90,950. (Finnhub fundamentals)
- Reports earnings on 2026-11-06, 15 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $1.86 actual vs. $1.25 estimated (+48.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 4
Strong sell 1
Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
GLP
+19.95%
vs S&P 500
+7.17%
1-YEAR RETURN
GLP
+11.01%
vs S&P 500
-3.55%
6-MONTH RETURN
GLP
+10.91%
3-MONTH RETURN
GLP
+4.04%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$1.86
Est. $1.25
BEAT +48.5%
2026-04-26 (Q1 2026)
$1.85
Est. $0.33
BEAT +455.1%
2026-01-26 (Q4 2025)
$0.54
Est. $0.61
MISS -10.9%
2025-10-26 (Q3 2025)
$0.66
Est. $1.10
MISS -40.0%
Valuation Measures & Ratios
Enterprise Value4$3.32B
Forward P/E510.88
PEG Ratio60.12
Price / Sales (TTM1)0.08
Price / Book72.12
EV4 / Revenue0.15
EV4 / EBITDA9.86
Profit Margin0.91%
Operating Margin1.55%
Return on Equity (ROE8)27.70%
Return on Assets (ROA9)4.92%
Avg Volume (3M)90,950
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short196,099
Change from Prior Settlement-18.49%
% of Float—
Days to Cover (Short Ratio)3.59
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 46.8% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +11.0%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 0.9%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-16; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on GLP
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.79B | $5.32B | $4.69B | $4.63B | $4.59B | $4.42B | $4.41B | $4.15B |
| Gross profit | $328.9M | $332.2M | $271.4M | $272.4M | $255.2M | $286.0M | $287.9M | $215.1M |
| Operating income | $107.4M | $105.7M | $61.4M | $60.1M | $55.9M | $83.5M | $83.9M | $25.8M |
| Net income | $71.0M | $70.1M | $29.0M | $25.2M | $18.7M | $45.9M | $46.1M | -$5.6M |
| Operating margin | $2 | $2 | $1 | $1 | $1 | $2 | $2 | $1 |
| Net margin | $1 | $1 | $1 | $1 | $0 | $1 | $1 | -$0 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $4.02B | $4.31B | $3.85B | $3.70B | $3.78B | $3.82B | $3.79B | $3.67B |
| Total liabilities | $3.27B | $3.60B | $3.18B | $3.02B | $3.10B | $3.12B | $3.07B | $2.94B |
| Total current assets | $1.43B | $1.71B | $1.23B | $1.13B | $1.22B | $1.24B | $1.21B | $1.12B |
| Total current liabilities | $1.20B | $1.52B | $1.08B | $933.9M | $1.03B | $1.07B | $1.00B | $983.3M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Accounts receivable | $706.3M | $772.9M | $530.1M | $521.5M | $564.0M | $577.5M | $472.6M | $471.9M |
| Inventory | $577.8M | $736.1M | $549.1M | $478.5M | $495.6M | $517.4M | $594.1M | $499.5M |
| Property, plant & equipment | $1.65B | $1.65B | $1.66B | $1.65B | $1.67B | $1.69B | $1.71B | $1.66B |
| Goodwill | $421.9M | $421.9M | $421.9M | $421.9M | $421.9M | $421.9M | $421.9M | $422.3M |
| Intangible assets | $10.8M | $12.1M | $13.3M | $14.6M | $15.9M | $17.3M | $18.7M | $19.4M |
| Other non-current assets | $32.1M | $36.5M | $38.4M | $40.2M | $41.4M | $41.2M | $38.7M | $41.6M |
| Accounts payable | $714.3M | $749.8M | $573.2M | $486.3M | $590.4M | $520.4M | $510.0M | $454.5M |
| Accrued liabilities | $204.7M | $189.7M | $207.6M | $167.2M | $179.4M | $145.6M | $223.3M | $182.5M |
| Other non-current liabilities | $62.3M | $62.7M | $69.5M | $68.4M | $67.3M | $68.1M | $76.6M | $60.5M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | $457.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $309.4M | -$104.7M | $101.0M | $19.0M | $216.3M | -$51.6M | $67.2M | $122.7M |
| Investing cash flow | -$31.2M | -$28.1M | -$36.2M | -$20.4M | -$15.9M | -$28.5M | -$46.5M | $1.8M |
| Financing cash flow | -$272.7M | $138.9M | -$70.6M | $3.2M | -$191.8M | $79.4M | -$33.1M | -$118.1M |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $5.8M | $7.4M | $3.3M | $3.4M | $3.3M | $3.5M | $4.1M | $4.7M |
| Deferred income taxes | — | — | $986.0K | — | — | — | -$5.4M | — |
| Change in accounts receivable | -$66.4M | $243.7M | $8.8M | -$42.2M | -$13.2M | $105.4M | $657.0K | -$130.2M |
| Change in inventory | -$158.1M | $187.0M | $70.6M | -$16.9M | -$21.8M | -$76.3M | $95.1M | -$65.6M |
| Change in accounts payable | -$35.5M | $176.6M | $86.9M | -$104.0M | $69.9M | $10.4M | $55.5M | -$103.4M |
| Share repurchases | $6.0M | — | $2.6M | $3.8M | $3.0M | $532.0K | $3.0M | $3.3M |
| Tax withholding on stock comp | $75.0K | $7.5M | $0 | $0 | $2.6M | $10.8M | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $18.56B | $17.16B | $16.49B | $18.88B | $13.25B |
| Gross profit | $1.06B | $1.06B | $973.6M | $1.10B | $719.3M |
| Operating income | $234.7M | $251.2M | $243.8M | $460.3M | $142.2M |
| Net income | $98.0M | $110.3M | $152.5M | $362.2M | $60.8M |
| Operating margin | $1 | $1 | $1 | $2 | $1 |
| Net margin | $1 | $1 | $1 | $2 | $0 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $3.85B | $3.79B | $3.45B | $3.16B | $2.83B |
| Total liabilities | $3.18B | $3.07B | $2.65B | $2.37B | $2.30B |
| Total current assets | $1.23B | $1.21B | $1.10B | $1.17B | $1.07B |
| Total current liabilities | $1.08B | $1.00B | $982.8M | $971.5M | $839.6M |
| Cash & equivalents | — | — | — | — | — |
| Accounts receivable | $530.1M | $472.6M | $551.8M | $478.8M | $411.2M |
| Inventory | $549.1M | $594.1M | $397.3M | $566.7M | $509.5M |
| Property, plant & equipment | $1.66B | $1.71B | $1.51B | $1.22B | $1.10B |
| Goodwill | $421.9M | $421.9M | $429.2M | $427.8M | $328.1M |
| Intangible assets | $13.3M | $18.7M | $20.7M | $26.9M | $26.0M |
| Other non-current assets | $38.4M | $38.7M | $37.5M | $30.7M | $32.3M |
| Accounts payable | $573.2M | $510.0M | $648.7M | $530.9M | $353.3M |
| Accrued liabilities | $207.6M | $223.3M | $179.9M | $157.0M | $138.7M |
| Other non-current liabilities | $69.5M | $76.6M | $61.2M | $57.3M | $53.5M |
| Accumulated other comprehensive income (loss) | — | — | $381.0K | -$449.0K | -$1.9M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $284.8M | $31.6M | $512.4M | $480.0M | $50.2M |
| Investing cash flow | -$101.0M | -$276.9M | -$492.4M | -$236.2M | -$115.0M |
| Financing cash flow | -$179.8M | $233.8M | -$4.5M | -$250.6M | $66.0M |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $13.4M | $15.5M | $10.6M | $2.7M | $707.0K |
| Deferred income taxes | $986.0K | -$5.4M | $2.5M | $9.6M | $599.0K |
| Change in accounts receivable | $58.8M | -$79.2M | $73.8M | $67.8M | $183.8M |
| Change in inventory | -$44.4M | $200.4M | -$172.1M | $52.1M | $123.9M |
| Change in accounts payable | $63.2M | -$138.7M | $117.8M | $177.6M | $145.4M |
| Share repurchases | $10.0M | $14.2M | $3.5M | $2.9M | $3.8M |
| Tax withholding on stock comp | $13.4M | $1.8M | $469.0K | $1.6M | $2.2M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding GLP as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-25 to 2026-09-21
Recent transactions
- Insiders have net bought 149,184 shares over the last 182 days, across 28 purchases and 0 sales.
- Most recent: Global GP LLC (General Partner) — Open market purchase of 5,000 shares on 2026-09-21.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)149,184 sh(28 txns)
Sales (open market)0 sh(0 txns)
Net Shares+149,184
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Global GP LLC | General Partner | Open market purchase | 2026-09-21 | 5,000 |
| Seabrook Kristin K. | Chief Legal Officer & Secy. | Option exercise | 2026-04-14 | 3,393 |
| Romaine Mark | Chief Operating Officer | Open market sale | 2026-03-25 | 2,065 |
| Hanson Gregory B. | Chief Financial Officer | Grant / award | 2026-02-25 | 32,618 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-21 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.63 |
| 2026-09-17 | Global GP LLC | General Partner | Open market purchase | 5,000 | $51.08 |
| 2026-09-16 | Global GP LLC | General Partner | Open market purchase | 5,000 | $50.55 |
| 2026-09-15 | Global GP LLC | General Partner | Open market purchase | 5,000 | $50.89 |
| 2026-09-14 | Global GP LLC | General Partner | Open market purchase | 5,000 | $52.20 |
| 2026-06-18 | Global GP LLC | General Partner | Open market purchase | 5,000 | $42.81 |
| 2026-06-17 | Global GP LLC | General Partner | Open market purchase | 5,000 | $43.28 |
| 2026-06-15 | Global GP LLC | General Partner | Open market purchase | 5,000 | $46.69 |
| 2026-06-12 | Global GP LLC | General Partner | Open market purchase | 5,000 | $46.50 |
| 2026-06-10 | Global GP LLC | General Partner | Open market purchase | 5,000 | $50.17 |
| 2026-06-09 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.44 |
| 2026-06-08 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.29 |
| 2026-06-04 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.50 |
| 2026-06-03 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.42 |
| 2026-06-02 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.19 |
| 2026-06-01 | Global GP LLC | General Partner | Open market purchase | 5,000 | $48.41 |
| 2026-05-29 | Global GP LLC | General Partner | Open market purchase | 5,000 | $47.22 |
| 2026-05-28 | Global GP LLC | General Partner | Open market purchase | 5,000 | $48.35 |
| 2026-05-27 | Global GP LLC | General Partner | Open market purchase | 5,000 | $48.94 |
| 2026-05-26 | Global GP LLC | General Partner | Open market purchase | 5,000 | $48.92 |
| 2026-05-22 | Global GP LLC | General Partner | Open market purchase | 4,184 | $50.05 |
| 2026-05-21 | Global GP LLC | General Partner | Open market purchase | 5,000 | $51.28 |
| 2026-05-20 | Global GP LLC | General Partner | Open market purchase | 10,000 | $51.19 |
| 2026-05-19 | Global GP LLC | General Partner | Open market purchase | 7,500 | $49.27 |
| 2026-05-18 | Global GP LLC | General Partner | Open market purchase | 7,500 | $48.86 |
| 2026-05-15 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.17 |
| 2026-05-14 | Global GP LLC | General Partner | Open market purchase | 5,000 | $49.35 |
| 2026-05-13 | Global GP LLC | General Partner | Open market purchase | 5,000 | $48.75 |
| 2026-04-14 | Global GP LLC | General Partner | Other acquisition/disposition | 3,393 | $45.86 |
| 2026-04-14 | Global GP LLC | General Partner | Other acquisition/disposition | 1,640 | $45.86 |
| 2026-04-14 | Seabrook Kristin K. | Chief Legal Officer & Secy. | Option exercise | 3,393 | $0.00 |
| 2026-04-14 | Seabrook Kristin K. | Chief Legal Officer & Secy. | Tax withholding | 1,640 | $45.86 |
| 2026-03-25 | Romaine Mark | Chief Operating Officer | Open market sale | 2,065 | $44.80 |
| 2026-03-23 | Romaine Mark | Chief Operating Officer | Open market sale | 435 | $47.31 |
| 2026-03-20 | Romaine Mark | Chief Operating Officer | Open market sale | 2,020 | $48.19 |
| 2026-03-19 | Romaine Mark | Chief Operating Officer | Open market sale | 3,245 | $48.10 |
| 2026-03-18 | Romaine Mark | Chief Operating Officer | Open market sale | 4,735 | $47.76 |
| 2026-03-17 | Romaine Mark | Chief Operating Officer | Open market sale | 7,500 | $47.39 |
| 2026-03-16 | Romaine Mark | Chief Operating Officer | Open market sale | 3,376 | $47.00 |
| 2026-03-13 | Romaine Mark | Chief Operating Officer | Open market sale | 900 | $47.50 |
| 2026-03-12 | Romaine Mark | Chief Operating Officer | Open market sale | 1,148 | $47.56 |
| 2026-03-11 | Romaine Mark | Chief Operating Officer | Open market sale | 1,649 | $48.03 |
| 2026-03-10 | Romaine Mark | Chief Operating Officer | Open market sale | 252 | $48.50 |
| 2026-03-09 | Romaine Mark | Chief Operating Officer | Open market sale | 2,500 | $48.00 |
| 2026-02-25 | Global GP LLC | General Partner | Other acquisition/disposition | 247,928 | $48.19 |
| 2026-02-25 | Global GP LLC | General Partner | Other acquisition/disposition | 119,871 | $48.19 |
| 2026-02-25 | Hanson Gregory B. | Chief Financial Officer | Grant / award | 32,618 | $0.00 |
| 2026-02-25 | Hanson Gregory B. | Chief Financial Officer | Tax withholding | 15,770 | $48.19 |
| 2026-02-25 | Romaine Mark | Chief Operating Officer | Grant / award | 47,210 | $0.00 |
| 2026-02-25 | Romaine Mark | Chief Operating Officer | Tax withholding | 22,826 | $48.19 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 02:55 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-16 | 8-K | 2026-10-16 | View on SEC.gov → |
| 2026-09-21 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-07 | View on SEC.gov → |
| 2026-07-30 | 8-K | 2026-07-30 | View on SEC.gov → |
| 2026-07-29 | 8-K | 2026-07-29 | View on SEC.gov → |
| 2026-06-29 | 8-K | 2026-06-29 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-16 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-09 | View on SEC.gov → |
| 2026-06-08 | 4 | 2026-06-04 | View on SEC.gov → |
Recent news
Headlines about GLP (Global Partners LP). Links open the publisher — we don’t host full articles.
-
Pennsylvania brothers facing 400 years for racketeering conspiracy, $32M Medicaid fraud; RFK Jr. undergoes surgery; GLP-1 users still love chocolate treats – Morning Medical Update
Medical Economics · 2026-10-21 -
Nationwide alert as 22 vials of GLP-1 medication Tirzepatide recalled over safety and sterility concerns
UNILAD · 2026-10-21 -
Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)
Benzinga · 2026-10-21 -
How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
TradingView · 2026-10-21 -
Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market
Zacks Investment Research · 2026-10-21 -
Menopause Therapy Might Boost GLP-1 Weight Loss
Newsmax · 2026-10-21 -
$522M genetic testing fraud scheme targets Medicare and Medicaid; Trump drug pricing deal projected to save $64.3B over 10 years; the future of GLP-1 drugs – Morning Medical Update
Medical Economics · 2026-10-21 -
FDA Issues Recall for Apothecary Pharma's Injectable GLP-1 Medications Due to Sterility Concerns
SSBCrack · 2026-10-21
No headlines in this category right now — try “All”.